• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Domnitz Yonatan

    3/18/26 3:17:32 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology
    Get the next $CLBT alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    Domnitz Yonatan

    (Last)(First)(Middle)
    94 SHLOMO SHMELZER ROAD

    (Street)
    PETAH TIKVA4970602

    (City)(State)(Zip)

    ISRAEL

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/18/2026
    3. Issuer Name and Ticker or Trading Symbol
    Cellebrite DI Ltd. [ CLBT ]
    3a. Foreign Trading Symbol
    [9W9]
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Ordinary Shares60,795D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Restricted Stock Units (1) (1)Ordinary Shares10,601(2)(2)D
    Explanation of Responses:
    1. The restricted stock units vest on September 17, 2026.
    2. Each restricted stock unit represents a contingent right to receive one ordinary share.
    /s/ Yonatan Domnitz03/18/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $CLBT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLBT

    DatePrice TargetRatingAnalyst
    3/28/2024$13.00 → $13.50Buy
    Needham
    3/13/2024Mkt Perform → Outperform
    William Blair
    2/16/2024$9.00 → $12.00Neutral → Buy
    BofA Securities
    7/19/2023$11.00Buy
    Craig Hallum
    8/12/2022$6.50 → $6.00Buy → Neutral
    BofA Securities
    8/12/2022Outperform → Mkt Perform
    William Blair
    2/24/2022$10.50Overweight
    JP Morgan
    2/11/2022$10.50Buy
    Deutsche Bank
    More analyst ratings

    $CLBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham reiterated coverage on Cellebrite DI with a new price target

    Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously

    3/28/24 8:25:08 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite DI upgraded by William Blair

    William Blair upgraded Cellebrite DI from Mkt Perform to Outperform

    3/13/24 7:29:30 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite DI upgraded by BofA Securities with a new price target

    BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously

    2/16/24 7:23:02 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cellebrite Launches Guardian Investigate, the AI-Powered Nerve Center that Revolutionizes How Investigative Teams Close Cases

     Investigators and AI agents together resolve cases faster across departments and agenciesTYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2026 /CNW/ -- Cellebrite (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the worldwide general availability of Guardian Investigate, a collaborative AI-powered investigative management solution that delivers a suite of capabilities for daily workflow collaboration across investigators, departments and agencies. Guardian Investigate is a radical shift for how investigators use AI across case files. They can now ask questions of their evidence, surface lin

    3/18/26 8:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite Changes the Investigative Game with the Launch of Genesis, the Groundbreaking Agentic AI Solution for Making Our World Safer

    Genesis to partner closely with detectives and investigators to convert tasks from weeks to minutes and turn mountains of artifacts into actionable insightsTYSONS CORNER, Va. and PETAH TIKVA, Israel, March 16, 2026 /PRNewswire/ -- Cellebrite (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today introduced early access to Cellebrite Genesis, a new purpose-built agentic AI product revolutionizing the way investigations get conducted. Cellebrite Changes the Investigative Game with the Launch of Genesi

    3/16/26 8:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite Files its 2025 Annual Report on Form 20-F

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 4, 2026 /PRNewswire/ -- Cellebrite (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC"). Cellebrite's 2025 Annual Report on Form 20-F is available on the investor relations section of its website at https://investors.cellebrite.com/financial-information/sec-filings and on the SEC's we

    3/4/26 8:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Domnitz Yonatan

    3 - Cellebrite DI Ltd. (0001854587) (Issuer)

    3/18/26 3:17:32 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Utsumi Ryusuke

    3 - Cellebrite DI Ltd. (0001854587) (Issuer)

    3/18/26 3:04:48 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by Cellebrite DI Ltd.

    3 - Cellebrite DI Ltd. (0001854587) (Issuer)

    3/18/26 8:26:08 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    SEC Filings

    View All

    SEC Form S-8 filed by Cellebrite DI Ltd.

    S-8 - Cellebrite DI Ltd. (0001854587) (Filer)

    3/3/26 4:59:47 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 20-F filed by Cellebrite DI Ltd.

    20-F - Cellebrite DI Ltd. (0001854587) (Filer)

    3/3/26 4:07:23 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Cellebrite DI Ltd.

    144 - Cellebrite DI Ltd. (0001854587) (Subject)

    2/24/26 4:31:54 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    Leadership Updates

    Live Leadership Updates

    View All

    Cellebrite Appoints Holly Windham as General Counsel and Chief Compliance Officer

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd (NASDAQ:CLBT), global leader in premier Digital Investigative and Intelligence solutions for the public and private sectors, today announced the appointment of Holly Windham as General Counsel and Chief Compliance Officer. Ms. Windham brings extensive legal leadership experience for growth-oriented technology companies with deep expertise spanning software, cloud platforms, cybersecurity, data privacy and public sector contracting – areas critical to Cellebrite's continued growth and market leadership. She will partner closely with Cellebrite's leadership team, overseeing all legal and complianc

    10/30/25 8:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite to Acquire Corellium

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its agreement to acquire Corellium, a leader in Arm-based virtualization software. This combination will set a new standard for digital investigations and the security of smart devices including iOS, Android, automotive systems and any Arm-based IoT device. Customers across public safety, defense, intelligence and private sectors will benefit from: Accelerated identification of mobile vulnerabilities and exploitsIndustry-first ability to visualize and interact with virtual dev

    6/5/25 7:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to

    1/6/25 8:00:00 AM ET
    $CLBT
    $CSCO
    Computer Software: Prepackaged Software
    Technology
    Computer Communications Equipment
    Telecommunications

    $CLBT
    Financials

    Live finance-specific insights

    View All

    Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results

    Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million Net income of $21.3 million supports non-GAAP net income of $36.7 million and adjusted EBITDA of $38.3 million, 29.8% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2026 /PRNewswire/ -- Cellebrite (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2025. "Cellebrite closed 2025 with a solid fourth quarter that capp

    2/11/26 7:00:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2025 financial results before the U.S. markets open on Wednesday, February 11, 2026. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2025 and discuss its 2026 outlook. Relevant details include: Date: Wednesday, February 1

    1/21/26 9:00:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite Announces Third-Quarter 2025 Results

    ARR grew 19% to $439.8 million; Revenue grew 18% to $126.0 million Net income of $20.2 million supports non-GAAP net income of $36.9 million and adjusted EBITDA of $37.7 million, 29.9% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and nine months ending September 30, 2025. "Cellebrite once again delivered a balanced and solid performance," stated Thomas E. Hogan, Cellebrite's CEO. "We exceeded the high end of our prior adjusted EBITDA guidance with revenue at the hi

    11/12/25 4:01:00 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

    SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

    9/17/24 4:33:52 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

    SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

    8/29/24 6:07:01 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Cellebrite DI Ltd. (Amendment)

    SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)

    3/12/24 12:38:56 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology